Platelet responsiveness and stent thrombosis
Links shared publicly online about this topic.
- 2,209total visits
Platelet responsiveness and stent thrombosis
View full resource at theheart.org
Tags: Anti-Clotting Medication, Plavix, Iscover
Most Recently Shared on March 6, 2009 at 10:33 pm By:
More support for clopidogrel platelet response testing http://tinyurl.com/ccgtef
Very Late Stent Thrombosis Approximately 7 Years After Deployment and One-Week Cessation of Dual Antiplatelet Therapy | Journal of Invasive Cardiology
invasivecardiology.com — “Very Late Stent Thrombosis Approximately 7 Years After Deployment and One-Week Cessation of Dual Antiplatelet Therapy | Journal of Invasive Cardiology” View full resource at invasivecardiology.com
Most Recently Shared on December 16, 2011 at 7:34 pm By:
Invasive Cardiology Cardiology and Medical Journal
Longest reported interval. Stent thrombosis 7 yrs post DES deployment -- 1 week after dual anti-platelet therapy stops. http://t.co/NC9N2XwQ
30-day results of ADAPT-DES registry reported at TCT 2011
medicalxpress.com — “The relationship of platelet responsiveness to antiplatelet medications; and, the correlation of poor response, and overall platelet aggregation while on dual antiplatelet therapy to the risk of drug-eluting stent thrombosis after 30 days was examined in ADAPT-DES, the largest registry to date to fully ...” View full resource at medicalxpress.com
Most Recently Shared on November 9, 2011 at 9:10 pm By:
PhysOrg Health News Health News
30-day results of ADAPT-DES registry reported at TCT 2011 http://t.co/7p8RDOJy
MedWire News - Thrombosis - Early stent thrombosis predictors identified
medwire-news.md — “MedWire News Variants in three genes associated with clopidogrel metabolism and platelet receptor function are independently associated with early stent thrombosis in patients undergoing percutaneous coronary intervention, study data show. MedWire News” View full resource at medwire-news.md
Most Recently Shared on October 27, 2011 at 9:25 am By:
Early stent thrombosis predictors identified http://t.co/e1Dcb2dA
More Data But No Answers About Platelet Function Testing - Forbes
forbes.com — “The RECLOSE 2–ACS (Responsiveness to Clopidogrel and Stent Thrombosis 2–ACS) trial from Italy provides new information about platelet reactivity but doesn't answer any of the key questions about the possible role of platelet function testing in clinical practice. In a paper published in JAMA, Guido Parodi and colleagues report on 1,789 ACS patients who underwent [...]” View full resource at forbes.com
Most Recently Shared on September 21, 2011 at 5:36 pm By:
Drugs and Devices OW OW Health
More Data But No Answers About Platelet Function Testing: The RECLOSE 2-ACS (Responsiveness to Clopidog... http://t.co/GhqQuk0I #drug
Lower achieved platelet reactivity associated with better cardiovascular
medicalxpress.com — “Compared to patients who had persistently high platelet reactivity, those who achieved low platelet reactivity, according to the VerifyNow P2Y12 Test, had a reduced incidence of cardiovascular death, heart attack and stent thrombosis, as indicated by a clinical trial presented today at the ESC Congress ...” View full resource at medicalxpress.com
Most Recently Shared on August 30, 2011 at 3:34 pm By:
PhysOrg Health News Health News
Lower achieved platelet reactivity associated with better cardiovascular http://t.co/WOBrksl
Internal Medicine - Cardiology Article | Myocardial infarction
mdlinx.com — “Relationship between clopidogrel-induced platelet P2Y12 inhibition and stent thrombosis or myocardial infarction after percutaneous coronary intervention-A case-control study” View full resource at mdlinx.com
Most Recently Shared on July 27, 2011 at 7:08 pm By:
Roger D. Jones, PhD Doctor, Health Executive, Health Social Media, and PhD
Internal Medicine - Cardiology Article | Myocardial infarction: http://t.co/Iw8hZ85 #Medicine
Symposier - A serious look at GRAVITAS - Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety
symposier.com — “Uploaded and shared in Youtube by: theheartorg — Heartwire's Sue Hughes sits down with Dr Sunil Rao to talk about the clinical implications of the results and what they mean for the future of platelet-function testing. http://www.theheart.org/editorial-program/1159543.do” View full resource at symposier.com
Most Recently Shared on June 9, 2011 at 12:04 am By:
Symposier Cardiology Cardiology and Health Business
A serious look at GRAVITAS - Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety. http://bit.ly/m5QZtK
Study examines outcomes of high-dose antiplatelet drug after stent placement
physorg.com — “Modifying a patient's dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient's level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty ...” View full resource at physorg.com
Most Recently Shared on March 15, 2011 at 9:08 pm By:
PhysOrg Health News Health News
Study examines outcomes of high-dose antiplatelet drug after stent placement http://tw.physorg.com/219427381
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement
newswise.com — “Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on March 15, 2011 at 8:23 pm By:
newswise Health Communicator and Health News
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient's dosage of th... http://bit.ly/hOcHHY
Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement
newswise.com — “Modifying a patient--™s dosage of the antiplatelet drug clopidogrel for 6 months depending on the patient--™s level of platelet reactivity did not result in combined lower rates of nonfatal heart attack, stent thrombosis (clot) and cardiovascular death in patients who had a procedure such as balloon angioplasty and received a drug-releasing coronary stent, according to a study in the March 16 issue of JAMA.” View full resource at newswise.com
Most Recently Shared on March 15, 2011 at 8:21 pm By:
#health news: Study Examines Outcomes of High-Dose Antiplatelet Drug After Stent Placement: Modifying a patient'... http://bit.ly/hmS7Qs
GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events
news-medical.net — “Accumetrics, Inc., developer and marketer of the VerifyNow System, today announced that the GRAVITAS (Gauging Responsiveness With A VerifyNow Assay-Impact On Thrombosis And Safety) Trial found that in patients with high residual platelet reactivity, doubling the maintenance dose of clopidogrel did not reduce the risk of further ischemic events after percutaneous coronary intervention (PCI).” View full resource at news-medical.net
Most Recently Shared on November 19, 2010 at 8:26 pm By:
Stroke News: GRAVITAS Trial finds high dose of clopidogrel does not reduce risk of ischemic events: Accumetric... http://twurl.nl/hydpwz
Clopidogrel response and cardiac death | theheart.org
theheart.org — “A platelet-reactivity index of over 60% on the VASP test was associated with an increased rate of death and stent thrombosis. The deleterious impact of a low response to clopidogrel was significantly higher in patients who received a drug-eluting stent.” View full resource at theheart.org
Most Recently Shared on June 28, 2010 at 11:19 am By:
James Rudd Cardiologist, Physician, Doctor, and Internist
Higher hard event rate with clopidogrel resistance after stenting http://www.theheart.org/article/1091207.do
plateletNEWS.org
plateletnews.org — “plateletNEWS.org” View full resource at plateletnews.org
Most Recently Shared on March 13, 2009 at 6:48 pm By:
plateletNEWS.org Cardiology and Health Site
Poll: Do you prescribe dual antiplatelet therapy to patients presenting with ACS on admission? Respond here: http://bit.ly/15oJt
Clopidogrel gene and stent thrombosis
theheart.org — “A polymorphism in one of the genes responsible for metabolizing clopidogrel to its active form has been shown to be associated with an increased risk of stent thrombosis in patients undergoing PCI. (Sibbing D et al. Eur Heart J; published online before print February 4, 2009.)” View full resource at theheart.org
Most Recently Shared on February 12, 2009 at 11:36 pm By:
Clopidogrel gene mutation linked to higher rate of stent thrombosis http://tinyurl.com/cxm6jp
Advertisement
